| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 18 | |
| #2 | WIPO (World Intellectual Property Organization) | 17 | |
| #3 | United Kingdom | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Special acyclic compounds | |
| #5 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bell Ian M | 35 |
| #2 | Stump Craig A | 18 |
| #3 | Zartman C Blair | 16 |
| #4 | Theberge Cory R | 12 |
| #5 | Gallicchio Steven N | 12 |
| #6 | Selnick Harold G | 11 |
| #7 | Fraley Mark E | 5 |
| #8 | Mitchell Helen J | 4 |
| #9 | Staas Donnette D | 4 |
| #10 | Wang Cheng | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US2012121508A1 | Radiolabeled cgrp antagonists | |
| US2010120809A1 | Aryl heterocyclic CGRP receptor antagonists | |
| WO2006029153A2 | Monocyclic anilide spirolactam cgrp receptor antagonists | |
| WO03035616A2 | Tyrosine kinase inhibitors | |
| WO03035615A2 | Tyrosine kinase inhibitors | |
| GB0023875D0 | Optiss |